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Children with end-stage kidney disease (ESKD) requiring dialysis and subsequent
transplantation are at risk for neurodevelopmental delays and deficits. Lower scores on
measures of IQ and academic achievement, as well as in specific cognitive domains of
language, visual-spatial perception, attention, memory, and executive function have been
documented by previous research [1,2]. These deficits have been corroborated with imaging
and electrophysiological investigations showing periventricular white matter lesions, cortical
atrophy, slower peripheral nerve conduction, and delayed myelination of the somatosensory
cortex [3]. Slickers and colleagues found that younger age of onset, longer duration of
kidney disease, and increased disease severity were associated with lower cognitive
functioning [4]. Although the relationship between kidney function and cognitive abilities is
not linear, pediatric populations progressing to ESRD and dialysis dependence appear to be
at increased risk for neurodevelopmental, intellectual, and related cognitive deficits [5].
Few studies have examined the impact of kidney transplant on cognitive function, and the
available evidence is inconclusive. Lawry and colleagues [6] compared the IQ scores of 9
children receiving dialysis, 2 children treated conservatively, and 13 transplant recipients. A
higher mean IQ was found in the transplanted group compared to the dialysis group,
although mean scores for both groups fell largely in the average range. Conversely,
Brouhard et al. [7] conducted a cross-sectional study comparing 26 children with transplant
to 26 dialysis dependent children and found no overall differences in intellectual
functioning. Even fewer studies have followed children with ESKD longitudinally in order
to assess the cognitive impact of receiving a kidney transplant. Mendley and Zelko [8] found
mental decision speed and sustained attention to be improved after transplant in a sample of
nine children with ESKD. Despite the relatively limited evidence for neurocognitive
improvement after pediatric kidney transplant, a neurobiological model would suggest that
improving kidney filtration should decrease the amount of neurotoxic exposure to the brain
which, in turn, may improve neuronal myelination and synaptic development as well as
overall neurological efficiency.
The current study seeks to examine the pre- and post-transplant neurocognitive function in a
small cohort of children with chronic kidney disease (CKD). It was hypothesized that
compared to a healthy control sample and pediatric CKD patients being treated
conservatively, children receiving transplants would show significant increases in
intellectual function during post-transplant follow-up.
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Six children with transplant, 20 children with CKD (no transplant), and 23 healthy children
were recruited as part of a larger investigation of neurocognitive function in pediatric CKD.
Baseline neuropsychological functioning has been reported previously for this cohort [2,4].
Patients with CKD were recruited from a university nephrology clinic; healthy control
subjects were recruited from the catchement area of the surrounding community. Inclusion
criteria for CKD patients were: 1) 0 to 18 years of age; and 2) Schwartz GFR < 90 ml/min/
1.73m2 or dialysis dependency for 3 months. Exclusion criteria were: 1) no prior kidney
transplant; and 2) no history of comorbid conditions associated with CNS anomalies. The
CKD group (no transplant) was comprised of children with moderate/severe CKD or
dialysis dependency. Seven children were classified as having moderate kidney disease
(GFR = 30-59 ml/min/1.73m2), 4 children were severe (GFR = 15-29 ml/min/1.73m2), and
15 children had progressed to end-stage kidney disease (GFR < 15 ml/min/1.73m2) or were
on dialysis. Inclusion criteria for the healthy control group were: 1) birth to 18 years of age;
2) no history of chronic health conditions, developmental disorders, head trauma,
neurological illness, or medication usage other than multivitamins. Maternal education was
obtained as a measure of socioeconomic status in children with CKD and the healthy control
group. Maternal education was coded as follow: 1 – less than high school diploma; 2 – high
school diploma or GED; 3 – two year vocational degree; 4 – four year college degree; and 5
– graduate or professional degree.
The CKD-transplant group was 10.7 years of age (range 5.3 – 17.9) with an average time
between visits of 12.8 months. Post-transplant evaluation occurred on average 6.3 months
after transplant. The CKD-transplant group was 50% male, 33.3% Caucasian, and 75%
right-handed. The average maternal education for the CKD-transplant group was 2.5. The
CKD-no transplant group was 7.8 years of age (range 0.2 – 16.2) with an average time
between visits of 10.9 months. This group was 65.0% male, 40% Caucasian, and 83% right-
handed. The average maternal education for the CKD-no transplant group was 2.8. The
healthy control group was 10.3 years of age (range 1.5 – 18.4) with an average time between
visits of 11.0 months. This group was 52% male, 87% Caucasian, and 94% right-handed.
The average maternal education for the healthy control group was 4.4. Upon entry to the
study, the baseline assessment was considered Time 1; Time 2 was considered either the
second visit for the CKD–no transplant and control groups, or the post-transplant visit for
the CKD-transplant group.
Procedures
Patients and control subjects received IQ or developmental testing at baseline and
approximately one year after baseline. Post transplant evaluation was given at a minimum
three months post transplant. The Mullen Scales of Early Learning (MSEL) was
administered to children five years of age or younger (n = 17). The Wechsler Abbreviated
Scale of Intelligence (WASI) was administered to children and adolescents 6 to 18 years of
age (n = 40). The MSEL and WASI provided measures of general developmental and
intellectual functioning, respectively. IQ and composite scores have a mean of 100 and a
standard deviation of 15. Across all of the groups, none of the participants moved from the
Mullen at Time 1 to the WASI at Time 2, thus limiting possible variance secondary to
changes in testing procedures. This study was reviewed and approved by the University of
North Carolina Institutional Review Board.
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Data were examined using SPSS 14.0 software. Any significant differences in demographic
variables were covaried in subsequent analyses. Change in developmental and/or intellectual
functioning over time was calculated as: (Time 2/Posttransplant Visit – Time 1). An
ANOVA was used to determine if children receiving transplant showed a greater increase
cognitive functioning over time compared to children with CKD not receiving transplant and
healthy controls. An additional chi-square analysis examined the effect size magnitude of
cognitive improvement from baseline measured via Cohen's d. Degree of improvement was




Children receiving transplant, children with CKD not receiving transplant, and the healthy
control group did not differ on age, F(2,46) = 1.39, p = ns, gender (χ2 = 0.86, p = ns),
handedness (χ2 = 1.62, p = ns), or time between visits F (2,46) = 0.61, p = ns. A significant
difference was found for race (χ2 = 15.93, p > .05) and maternal education F(2, 40) = 19.03,
p < .001). Covarying race and maternal education did not change the outcome of the analysis
and were, therefore, not covaried in the final analysis due loss of power from missing data.
Cognitive Improvement
Across the three groups, a significant difference was found between Time 1 and Time 2
assessments, F (2,54) = 4.68, p < .05. Means and standard deviations are presented in Table
1. Post-hoc analysis using a Bonferonni correction for multiple comparisons showed that
children receiving transplants had a significant increase in intellectual functioning compared
to children with CKD not receiving transplant (p < .05). The effect size for the difference
between these two groups was large (Cohen's d = 1.12). Children receiving transplant had
mean change in IQ of 12.17 points (SD = 12.02). Children with CKD not receiving
transplant had a mean change in IQ of -3.45 points (SD = 15.53). The healthy control group
had a mean change in IQ of 3.00 points (SD = 5.68). Although children receiving transplant
had approximately a ten-point greater increase in IQ than the healthy control group this
difference was not significant; however, the effect size was large (Cohen's d = 0.98) and
greater than would be expected given normal development.
Conversely, analysis of the magnitude of cognitive improvement (i.e., effect size) between
the three groups was not significant (χ2 = 6.99, p = ns.). However, for the CKD group
receiving transplant, 33% had cognitive increases greater than or equal to two-thirds a
standard deviation (≥ 12 points), 16.7% had a moderate increase (8 – 11 points), and 33.3%
had a small increase (3 – 7 points). Comparatively, within the CKD group not receiving
transplant, 15.0% had a small increase, 20.0% had a moderate increase, and 5.0% had an
increase that would be considered large. For the healthy control group, 30.4% had a small
change, 17.4 % had a moderate change, and 8.7% had large changes in cognitive function.
Discussion
The current study examined the impact of pediatric kidney transplantation on the cognitive
and developmental functioning of children with CKD. Although a relatively small sample
was examined, this one of only a few studies which examined the impact of kidney
transplant on developmental and intellectual functioning in children. In general, findings
from this study suggest that children with CKD receiving transplant evidenced significant
improvement in their overall cognitive function after transplant. Specifically, children with
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CKD receiving transplant showed approximately a 12-point increase in intellectual
functioning, which descriptively went from the borderline range to the low average range.
Although transplant did not appear to normalize developmental status or intellectual
functioning, these findings support previous investigations espousing the overall benefits of
pediatric kidney transplantation on cognitive abilities [8]. Children with CKD not receiving
transplants showed a mild decrease in intellectual function (3 points) by their second visit,
which may be related to environmental effects or, perhaps, worsening kidney function.
As previously mentioned, a neurobiological model of the relationship between kidney
function and brain development would suggest that improving kidney filtration, and
subsequently decreasing the amount of neurotoxins in the bloodstream, would be beneficial
for brain growth and performance. Given that childhood and adolescence are important time
periods for brain myelination and synaptic development, the potential neurocognitive impact
of CKD and its associated symptoms (e.g., hypertension, anemia, uremia) is of great
concern. The significant improvement seen in our small sample supports this model;
however, it is important to note that other researchers have not found significant differences
in cognitive performance between dialysis dependent and transplant cohorts [7]. In addition,
other research has suggested that cognitive improvements after transplant may be related to
multiple factors including diminished aluminum burden and better nutritional regulation [9].
Over the past decades, we have acknowledged the burden of CKD and uremia on cognition,
and we have provided pilot data that transplantation can reduce this burden. As we currently
manage approximately 7,000 children with ESRD in the USA, and much larger numbers
globally [10], it will be important to continue to examine this issue, perhaps from a multi-
disciplinary, multi-center, prospective investigation in an effort to more definitively address
this question.
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Table 1
Composite IQ/Developmental Scores over Time (Mean = 100, SD = 15).
Group Time 1 Time 2
CKD – Transplant 72.83 (19.95) 85 (19.04)
CKD – No Transplant 87.15 (17.78) 83.55 (23.58)
Control 115.13 (16.49) 118.13 (15.13)
Note. Scores represent a combination of the Mullen Early Learning Composite and the WASI Full-4 IQ
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